Straumann Holding AG (SAUHF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Straumann Holding AG (SAUHF) trades at $131.11 with AI Score 52/100 (Grade B). Straumann Holding AG specializes in tooth replacement and orthodontic solutions, providing a wide range of dental products and services globally. Market cap: $20.91B, Sector: Healthcare.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for SAUHF: SAUHF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SAUHF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
SAUHF: 4/7 perspectives are bullish. Dominant signal: Ken Griffin bullish.
How is this calculated? →Straumann Holding AG (SAUHF) Healthcare & Pipeline Overview
Straumann Holding AG is a global leader in dental implant solutions, offering a comprehensive portfolio of products and services including dental implants, orthodontic aligners, and digital solutions, catering to a diverse clientele across approximately 100 countries.
What Is the Investment Thesis for SAUHF?
Straumann Holding AG is well-positioned for sustained growth, driven by robust demand for dental implant solutions and orthodontic products. With a market capitalization of $20.91B and a profit margin of 13.7%, the company demonstrates strong financial health. The dental implant market is projected to grow significantly, with increasing awareness of oral health and advancements in dental technology. Key growth catalysts include the expansion of digital dental solutions and the rising prevalence of dental disorders. Additionally, Straumann's focus on research and development, along with strategic partnerships, enhances its competitive advantage. However, potential risks include regulatory challenges and competition from established players in the dental market.
Based on FMP financials and quantitative analysis
SAUHF Key Highlights
- Market cap of $20.91B reflects strong investor confidence in the dental implant sector.
- P/E ratio of 46.5 indicates premium valuation due to growth expectations.
- Profit margin of 13.7% showcases efficient operations and cost management.
- Gross margin of 68.7% exceeds industry averages, highlighting product pricing power.
- Dividend yield of 1.07% provides a return to shareholders while reinvesting for growth.
Who Are SAUHF's Competitors?
SAUHF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ESLOY EssilorLuxottica S.A. | $99.01 | -1.17% | $91.01B | 49 |
| BDX Becton, Dickinson and Company | $156.38 | -1.08% | $56.65B | 72 |
| ALC Alcon Inc. | $68.47 | -1.71% | $33.39B | 51 |
| RMD ResMed Inc. | $220.60 | +5.23% | $32.00B | 95 |
| WST West Pharmaceutical Services, Inc. | $357.68 | -2.20% | $25.27B | 94 |
| NYXH Nyxoah S.A. | $1.75 | +1.74% | $69.31M | 69 |
| KMTS Kestra Medical Technologies, Ltd. | $27.70 | +2.67% | $1.62B | 67 |
| ZTEK Zentek Ltd. | $0.46 | +2.88% | $49.90M | 63 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SAUHF's Key Strengths?
- Leading position in the dental implant market with a strong brand.
- High gross margin of 68.7%, indicating strong pricing power.
- Robust R&D pipeline driving innovation in dental solutions.
- Extensive distribution network facilitating global reach.
What Are SAUHF's Weaknesses?
- High dependency on the dental implant segment for revenue.
- Exposure to regulatory changes affecting product approvals.
- Premium pricing may limit market penetration in cost-sensitive regions.
- Potential supply chain disruptions impacting product availability.
What Could Drive SAUHF Stock Higher?
- Launch of new digital dental solutions expected in Q4 2026.
- Expansion into emerging markets, particularly in Asia-Pacific.
- Continuous investment in R&D to enhance product offerings.
- Strategic partnerships with dental service organizations to increase market reach.
- Growing demand for orthodontic aligners driving sales.
What Are the Key Risks for SAUHF?
- Rich valuation — a P/E of 46.5 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.
- Regulatory challenges that may impact product approvals.
- Intense competition from established players in the dental market.
- Economic downturns affecting consumer spending on dental care.
- Supply chain disruptions impacting product availability.
What Are the Growth Opportunities for SAUHF?
- Digital Solutions Expansion: The growing adoption of digital dentistry presents significant growth opportunities for Straumann. The digital dental solutions market is expected to grow from USD 3.5 billion in 2023 to USD 7.2 billion by 2030, driven by technological advancements and increased demand for efficient dental practices. Straumann's investments in digital solutions, such as intraoral scanners and CADCAM systems, position it to capture a larger market share.
- Orthodontic Aligners Market: The orthodontic aligners segment is rapidly expanding, with the global market projected to reach USD 6.2 billion by 2027. Straumann's Clear Correct aligners are well-positioned to benefit from this trend, as more patients seek discreet and effective teeth alignment solutions. The company's focus on innovation and customer education will enhance its competitive edge in this growing segment.
- Emerging Markets Penetration: Straumann aims to expand its presence in emerging markets, where dental care access is improving. The dental market in Asia-Pacific is expected to grow at a CAGR of 7.5% from 2023 to 2030. By leveraging its distribution network and partnerships, Straumann can tap into this growth potential and increase its market share in these regions.
- Biomaterials Development: The biomaterials market for dental applications is projected to reach USD 2.5 billion by 2026. Straumann's commitment to developing innovative biomaterials and biologics for dental applications positions it to capitalize on this growing demand. The company's research in soft tissue management and oral healing products will further enhance its product offerings.
- Training and Education Services: As dental technologies evolve, the need for training and education in the dental field is increasing. Straumann's focus on providing comprehensive training services to dental professionals will strengthen customer loyalty and enhance product utilization. This strategy will not only drive sales but also position Straumann as a thought leader in dental education.
What Opportunities Does SAUHF Have?
- Expansion into emerging markets with growing dental care needs.
- Increasing demand for digital dental solutions and technologies.
- Development of innovative biomaterials for enhanced dental procedures.
- Growing market for orthodontic treatments, particularly clear aligners.
What Threats Does SAUHF Face?
- Intense competition from established players in the dental market.
- Economic downturns affecting consumer spending on dental care.
- Regulatory hurdles that may delay product launches.
- Technological advancements by competitors that could erode market share.
What Are SAUHF's Competitive Advantages?
- Strong brand reputation built on decades of innovation in dental care.
- Comprehensive product portfolio that addresses diverse dental needs.
- Robust research and development capabilities driving continuous innovation.
- Established global distribution network ensuring market accessibility.
- Commitment to training and education, enhancing customer relationships.
What Does SAUHF Do?
Founded in 1954, Straumann Holding AG has established itself as a prominent player in the dental healthcare sector, focusing on tooth replacement and orthodontic solutions. Headquartered in Basel, Switzerland, the company operates on a global scale, providing innovative products and services to general dentists, specialists, and dental technicians in nearly 100 countries. Straumann's product offerings include a wide range of dental implants, instruments, CADCAM prosthetics, orthodontic aligners, and biomaterials. The company has continually evolved its product line to meet the demands of the dental market, introducing advanced technologies such as intraoral scanning solutions and 3D printing capabilities. Straumann's commitment to research and development has positioned it at the forefront of dental innovation, allowing it to deliver high-quality solutions that enhance patient outcomes. The company also emphasizes education and training for its customers, ensuring that dental professionals are well-equipped to utilize its products effectively. With a workforce of over 11,000 employees, Straumann is dedicated to improving dental care worldwide, leveraging its extensive distribution network to reach a diverse customer base, including hospitals, universities, and dental service organizations.
What Products and Services Does SAUHF Offer?
- Develops and manufactures dental implants for tooth replacement.
- Offers orthodontic solutions, including Clear Correct aligners.
- Provides digital solutions for dental labs and practices.
- Supplies surgical instruments and biomaterials for dental procedures.
- Delivers training and education services to dental professionals.
- Operates in approximately 100 countries through a global distribution network.
How Does SAUHF Make Money?
- Generates revenue through the sale of dental implants and related products.
- Offers digital solutions and services to enhance dental practice efficiency.
- Provides training and education services to dental professionals, creating customer loyalty.
- Partners with distributors and dental service organizations to expand market reach.
- Invests in research and development to innovate and improve product offerings.
What Industry Does SAUHF Operate In?
The dental implant market is experiencing robust growth, driven by rising awareness of oral health and advancements in dental technology. The global dental implants market size is projected to reach USD 12.8 billion by 2028, growing at a CAGR of 6.8%. Straumann Holding AG operates within a competitive landscape, facing rivals such as EssilorLuxottica S.A. (ESLOY), Becton, Dickinson and Company (BDX), Alcon Inc. (ALC), ResMed Inc. (RMD), and West Pharmaceutical Services, Inc. (WST). The company's innovative product portfolio and commitment to research and development position it favorably against these competitors.
Who Are SAUHF's Key Customers?
- General dentists seeking reliable tooth replacement solutions.
- Dental specialists focusing on advanced orthodontic treatments.
- Dental technicians and laboratories requiring high-quality materials.
- Corporate customers, including hospitals and universities.
- Dental service organizations looking for comprehensive dental solutions.
How Straumann Holding AG Is Valued
Straumann Holding AG carries a market capitalization of $20.91B, placing it in the large-cap category. Relative to its peer group, SAUHF's quantitative score of 52/100 is below the peer average of 72/100.
Company Profile
Straumann Holding AG operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Basel, CH. The company is led by CEO Guillaume Daniellot. SAUHF has traded publicly since 2010.
ROE 17%Key Financial Metrics
Return on equity for Straumann Holding AG stands at 16.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 9.3%, showing how much profit it generates from its asset base. SAUHF trades at a trailing price-to-earnings ratio of 46.52, above the Healthcare sector average of ~23x. Its free cash flow yield is 1.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.21 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.1%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 7/9Financial Health
Straumann Holding AG's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 9.92 places it in the safe zone, indicating low near-term bankruptcy risk.
FY2026 estForward Outlook
Wall Street analysts project Straumann Holding AG revenue of about $2.70B for fiscal 2026, with EPS near $3.12. The estimate reflects 16 contributing analysts.
SAUHF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Leading position in the dental implant market with a strong brand.
- High gross margin of 68.7%, indicating strong pricing power.
- Robust R&D pipeline driving innovation in dental solutions.
- Extensive distribution network facilitating global reach.
Bear Case
- High dependency on the dental implant segment for revenue.
- Exposure to regulatory changes affecting product approvals.
- Premium pricing may limit market penetration in cost-sensitive regions.
- Potential supply chain disruptions impacting product availability.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
SAUHF Latest News
No recent news available for SAUHF.
SAUHF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SAUHF.
Price Targets
Wall Street price target analysis for SAUHF.
SAUHF MoonshotScore
What does this score mean?
The MoonshotScore rates SAUHF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Guillaume Daniellot
CEO
Guillaume Daniellot has extensive experience in the healthcare sector, holding various leadership roles in multinational companies. He has a strong background in business management and strategy, having graduated with a degree in Business Administration. His career includes significant positions in operations and marketing, where he has driven growth and innovation.
Track Record: Under Daniellot's leadership, Straumann has expanded its global footprint and enhanced its product offerings, particularly in digital solutions. His strategic focus on research and development has led to the introduction of several innovative products, strengthening the company's competitive position.
SAUHF OTC Market Information
The OTC Other tier includes companies that do not meet the requirements for higher tiers like NYSE or NASDAQ. These companies may have less stringent reporting requirements and are often less liquid than those listed on major exchanges.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Lower liquidity compared to stocks listed on major exchanges, leading to potential price volatility.
- Less stringent reporting requirements may result in less transparency for investors.
- Increased susceptibility to market manipulation due to lower trading volumes.
- Potential difficulty in obtaining accurate and timely information about the company.
- Verify the company's financial health through recent financial statements.
- Assess the competitive landscape and market positioning.
- Review recent news and developments impacting the company.
- Evaluate management's track record and strategic vision.
- Examine the company's growth strategy and market expansion plans.
- Established history since 1954, indicating stability and experience.
- Strong brand recognition in the dental healthcare sector.
- Commitment to research and development, showcasing innovation.
- Global distribution network and partnerships with reputable organizations.
What Investors Ask About Straumann Holding AG (SAUHF) — Healthcare
What does Straumann Holding AG do?
Straumann Holding AG specializes in dental solutions, providing a comprehensive range of products including dental implants, orthodontic aligners, and digital solutions for dental practices. The company serves general dentists, specialists, and dental technicians across approximately 100 countries, focusing on innovative technologies to improve patient outcomes.
What are the main risks for SAUHF?
Key risks for Straumann Holding AG include regulatory challenges that may affect product approvals, intense competition from established players in the dental market, and economic downturns that could reduce consumer spending on dental care. Additionally, potential supply chain disruptions could impact the availability of products, affecting sales.
How does Straumann Holding AG manage patent expiration risks?
Straumann Holding AG actively manages patent expiration risks by investing in research and development to innovate and introduce new products. The company also focuses on lifecycle management strategies, ensuring that its product portfolio remains competitive even as patents expire. By continuously enhancing its offerings, Straumann aims to mitigate the impact of competition from generic alternatives.
What are the key factors to evaluate for SAUHF?
Straumann Holding AG (SAUHF) holds an AI score of 52/100 (moderate). P/E: 46.5x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does SAUHF data refresh on this page?
SAUHF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven SAUHF's recent stock price performance?
Straumann Holding AG (SAUHF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Leading position in the dental implant market with a strong brand. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SAUHF overvalued or undervalued right now?
Straumann Holding AG (SAUHF) trades at 46.5x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying SAUHF?
Before investing in Straumann Holding AG (SAUHF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Data is based on the latest available financial and operational information.